Skip Navigation
American College of Physicians Logo
  • Subscribe
  • Submit a Manuscript
  • Sign In
    Sign in below to access your subscription for full content
    INDIVIDUAL SIGN IN
    Sign In|Set Up Account
    You will be directed to acponline.org to register and create your Annals account
    INSTITUTIONAL SIGN IN
    Open Athens|Shibboleth|Log In
    Annals of Internal Medicine
    SUBSCRIBE
    Subscribe to Annals of Internal Medicine.
    You will be directed to acponline.org to complete your purchase.
Annals of Internal Medicine Logo Menu
  • Latest
  • Issues
  • Channels
  • CME/MOC
  • In the Clinic
  • Journal Club
  • Web Exclusives
  • Author Info
Advanced Search
  • ‹ PREV ARTICLE
  • This Issue
  • NEXT ARTICLE ›
Summaries for Patients |1 July 2003

Hepatitis G Virus Co-Infection Slows Progression from HIV Infection to AIDS: The Potential Role of Cytokines

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information

  • The summary below is from the full report titled Slower Progression of HIV-1 Infection in Persons with GB Virus C Co-Infection Correlates with an Intact T-Helper 1 Cytokine Profile. It is in the 1 July 2003 issue of Annals of Internal Medicine (volume 139, pages 26-30). The authors are G. Nunnari, L. Nigro, F. Palermo, M. Attanasio, A. Berger, H.W. Doerr, R.J. Pomerantz, and B. Cacopardo.


Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians.
×
  • ‹ PREV ARTICLE
  • This Issue
  • NEXT ARTICLE ›
Jump To
  • Full Article
  • FULL ARTICLE
  • FULL ARTICLE
    • What is the problem and what is known about it so far?
    • Why did the researchers do this particular study?
    • Who was studied?
    • How was the study done?
    • What did the researchers find?
    • What were the limitations of the study?
    • What are the implications of the study?
  • Figures
  • Tables
  • Supplements
  • Audio/Video
  • Summary for Patients
  • Clinical Slide Sets
  • CME / MOC
  • Comments
  • Twitter Link
  • Facebook Link
  • Email Link
More
  • LinkedIn Link

What is the problem and what is known about it so far?

Infection with HIV causes AIDS, a serious illness that interferes with the immune system. People with AIDS lose the ability to fight infection and certain types of cancer. However, many people with HIV infection remain healthy for years before developing AIDS. Hepatitis G virus (also known as GB virus C [GBV-C]) is another virus that, like HIV, is transmitted through contact with the blood of a person who has the infection. Many people who inject illegal drugs, such as heroin, into their blood have GBV-C infection. Unlike HIV, GBV-C does not cause serious illness. In fact, studies show that people who have HIV infection progress to AIDS more slowly if they also have GBV-C infection (co-infection). We do not know how GBV-C slows HIV infection. Some researchers think that GBV-C might interact with the immune system in a beneficial way.

Why did the researchers do this particular study?

To see whether substances called T-helper 1 cytokines differ in patients with HIV and GBV-C co-infection compared with patients with only HIV infection. These cytokines are substances involved in the immune system and are related to the development of AIDS.

Who was studied?

80 patients at a medical center in Italy who had HIV infection but no symptoms in 1989. All of the patients had used injection drugs.

How was the study done?

The researchers examined the study patients every 6 months for up to 8 years. Each examination included blood tests for signs of progression to AIDS (tests called CD4 cell counts and viral load levels) and for levels of T-helper 1 cytokines. The researchers also tested each patient for GBV-C infection. They then compared the development of AIDS and the cytokine levels in people with and without GBV-C co-infection.

What did the researchers find?

Of the 80 HIV-infected patients, 17 also had GBV-C infection. As in previous studies, the patients with both HIV and GBV-C infection progressed to AIDS more slowly than did patients with only HIV infection. However, this study also showed that, over 8 years, levels of the immune substances called T-helper 1 cytokines decreased in patients with only HIV infection but stayed stable in patients who also had GBV-C infection.

What were the limitations of the study?

This was a relatively small study of people from a single geographic area. In addition, it does not prove that GBV-C infection exerts its benefit in people with HIV by influencing cytokine levels.

What are the implications of the study?

This study shows that GBV-C infection is associated with a lack of change in the immune substances called T-helper 1 cytokines in people with HIV infection. These results suggest a possible reason why people with HIV infection progress to AIDS more slowly if they also have GBV-C infection.

This feature is available only to Registered Users

Subscribe/Learn More
Submit a Comment

0 Comments

PDF
Not Available
Citations
Citation

Hepatitis G Virus Co-Infection Slows Progression from HIV Infection to AIDS: The Potential Role of Cytokines. Ann Intern Med. 2003;139:I–65. doi: https://doi.org/10.7326/0003-4819-139-1-200307010-00004

Download citation file:

  • Ris (Zotero)
  • EndNote
  • BibTex
  • Medlars
  • ProCite
  • RefWorks
  • Reference Manager

© 2020

×
Permissions

Published: Ann Intern Med. 2003;139(1):I-65.

DOI: 10.7326/0003-4819-139-1-200307010-00004

©
2003 American College of Physicians
0 Citations
Advertisement

See Also
Slower Progression of HIV-1 Infection in Persons with GB Virus C Co-Infection Correlates with an Intact T-Helper 1 Cytokine Profile
View MoreView Less

Related Articles
Slower Progression of HIV-1 Infection in Persons with GB Virus C Co-Infection Correlates with an Intact T-Helper 1 Cytokine Profile
Annals of Internal Medicine; 139 (1): 26-30
Host Determinants in HIV Infection and Disease: Part 2: Genetic Factors and Implications for Antiretroviral Therapeutics*
Annals of Internal Medicine; 134 (10): 978-996
Effect of Hepatitis G Virus Infection on Progression of HIV Infection in Patients with Hemophilia
Annals of Internal Medicine; 132 (12): 959-963
Effect of Hepatitis G Virus Infection on Progression of HIV Infection in Patients with Hemophilia
Annals of Internal Medicine; 132 (12): 959
View MoreView Less

Journal Club
TDF-FTC before and after sex reduced HIV infection but increased GI, renal events in men who have sex with men
Annals of Internal Medicine; 164 (6): JC28
Preexposure tenofovir–emtricitabine reduced HIV infection in men who have unprotected anal sex with men
Annals of Internal Medicine; 164 (2): JC3
In early HIV infection, immediate vs deferred antiretroviral therapy reduced serious illnesses at 3 years
Annals of Internal Medicine; 163 (12): JC4
Prophylactic tenofovir reduced HIV infection in injectable drug users
Annals of Internal Medicine; 159 (6): JC8
View MoreView Less

Related Point of Care
Management of Newly Diagnosed HIV Infection
Annals of Internal Medicine; 167 (1): ITC1-ITC16
Management of Newly Diagnosed HIV Infection
Annals of Internal Medicine; 155 (7): ITC4-1
View MoreView Less

Related Topics
Gastroenterology/Hepatology
HIV
Infectious Disease
Viral Hepatitis

Gastroenterology/Hepatology, HIV, Infectious Disease, Viral Hepatitis.

PubMed Articles
Dose-escalation trial of budesonide in surfactant for prevention of bronchopulmonary dysplasia in extremely low gestational age high-risk newborns (SASSIE).
Pediatr Res 2020.
microRNAs expression in relation to particulate matter exposure: A systematic review.
Environ Pollut 2020;
View More

Results provided by: PubMed

Advertisement
CME/MOC Activity Requires Users to be Registered and Logged In.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
The Comments Feature Requires Users to be Registered and Logged In.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
link to top

Content

  • Home
  • Latest
  • Issues
  • Channels
  • CME/MOC
  • In the Clinic
  • Journal Club
  • Web Exclusives

Information For

  • Author Info
  • Reviewers
  • Press
  • Readers
  • Institutions / Libraries / Agencies
  • Advertisers

Services

  • Subscribe
  • Renew
  • Alerts
  • Current Issue RSS
  • Latest RSS
  • In the Clinic RSS
  • Reprints & Permissions
  • Contact Us
  • Help
  • About Annals
  • About Mobile
  • Patient Information
  • Teaching Tools
  • Annals in the News
  • Share Your Feedback

Awards and Cover

  • Personae (Cover Photo)
  • Junior Investigator Awards
  • Poetry Prize

Other Resources

  • ACP Online
  • Career Connection
  • ACP Advocate Blog
  • ACP Journal Wise

Follow Annals On

  • Twitter Link
  • Facebook Link
acp link acp
silverchair link silverchair

Copyright © 2020 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
INSTITUTIONAL SIGN IN
Open Athens|Shibboleth|Log In
Annals of Internal Medicine
PURCHASE OPTIONS
Buy This Article|Subscribe
You will be redirected to acponline.org to sign-in to Annals to complete your purchase.
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×